This list contains only the countries for which job offers have been published in the selected language (e.g., in the French version, only job offers written in French are displayed, and in the English version, only those in English).
Beam is seeking a highly motivated and strategic Associate Director, Investor Relations to join our growing Investor Relations and External Communications team at a pivotal moment in the company's evolution. In this role, you will support the execution of Beam's investor relations strategy and play a central part in shaping how Beam's science, pipeline, and corporate narrative are communicated to the investment community. You will partner closely with senior leadership, finance, legal, corporate communications, and program teams to translate complex clinical and scientific milestones into clear, compelling, investor-ready messaging across earnings cycles, conferences, and one-on-one engagements. This position is critical to building a best-in-class IR function as Beam transitions from a clinical-stage to commercial-stage biotechnology company delivering on the promise of base editing for patients with serious diseases.
Job Responsibility
Support execution of Beam’s investor relations strategy, including proactive engagement with buy-side and sell-side investors
Help manage investor targeting, outreach, and meeting coordination for one-on-ones, conferences, and non-deal roadshows
Track investor sentiment, ownership trends, and peer activity to inform outreach strategy and positioning
Serve as a secondary point of contact for inbound investor and analyst inquiries
Support continuous improvement of IR best practices and infrastructure
Support preparation of key disclosures and quarterly earnings materials, including scripts, slide decks, Q&A documents, and press releases
Help ensure accuracy, consistency, and compliance across external disclosures in coordination with legal and finance
Manage internal consensus models
Work cross-functionally with R&D, Clinical Development, Regulatory, and Commercial teams to: stay current on program updates and key milestones
translate technical data into clear, investor-relevant narratives
and support investor-facing materials related to clinical data readouts, regulatory updates, and pipeline evolution
Help refine and maintain Beam’s corporate narrative as the company evolves from a clinical-stage to commercial-stage biotech
Assist in message testing and preparation of executive spokespeople
Manage updates to Beam’s investor website and coordinate with Corporate Communications on broader digital and website strategy and content
Requirements
5–8 years of experience in investor relations, equity research, investment banking, corporate finance, or strategic communications, with meaningful exposure to public biotechnology or life sciences companies
Strong understanding of capital markets, public company disclosure requirements, and investor expectations
Ability to synthesize complex scientific, clinical, and financial information into clear, concise messaging
Proven written and verbal communication skills
High attention to detail and strong project management capabilities
Comfortable operating in a fast-paced, highly cross-functional environment
Nice to have
Prior experience supporting a pipeline-driven biotech company with multiple clinical programs
Exposure to companies approaching or undergoing a transition to commercial stage
Familiarity with gene editing, genetic medicine, or other advanced therapeutic modalities
Experience interacting directly with investors or analysts